{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:36:25Z","timestamp":1790696185652,"version":"4.1.0"},"reference-count":94,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Mesenchymal stem cells (MSCs) have been proposed as a potential therapeutic tool for Parkinson's disease (PD) and systemic administration of these cells has been tested in preclinical and clinical studies. However, no information on survival and actual capacity of MSCs to reach the brain has been provided. In this study, we evaluated homing of intraarterially infused rat MSCs (rMSCs) in the brain of rats bearing a 6-hydroxydopamine (6-OHDA)-induced lesion of the nigrostriatal tract, to establish whether the toxin-induced damage is sufficient to grant MSC passage across the blood-brain barrier (BBB) or if a transient BBB disruption is necessary. The rMSC distribution in peripheral organs and the effects of cell infusion on neurodegenerative process and motor deficits were also investigated. rMSCs were infused 14 days after 6-OHDA injection. A hyperosmolar solution of mannitol was used to transiently permeabilize the BBB. Behavioral impairment was assessed by adjusting step test and response to apomorphine. Animals were sacrificed 7 and 28 days after cell infusion. Our work shows that appreciable delivery of rMSCs to the brain of 6-OHDA-lesioned animals can be obtained only after mannitol pretreatment. A notable percentage of infused cells accumulated in peripheral organs. Infusion of rMSCs did not modify the progression of 6-OHDA-induced damage or the motor impairment at the stepping test, but induced progressive normalization of the pathological response (contralateral turning) to apomorphine administration. These findings suggest that many aspects should be further investigated before considering any translation of MSC systemic administration into the clinical setting for PD treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>This study demonstrates that mesenchymal stem cells infused through the carotid artery do not efficiently cross the blood-brain barrier in rats with a Parkinson's disease-like degeneration of nigrostriatal neurons, unless a permeabilizing agent (e.g., mannitol) is used. The infusion did not reduce the neuronal damage and associated motor impairment, but abolished the motor abnormalities these animals typically show when challenged with a dopaminergic agonist. Therefore, although arterially infused mesenchymal stem cells did not show neurorestorative effects in this study's Parkinson's disease model, they appeared to normalize the pathological responsiveness of striatal neurons to dopaminergic stimulation. This capability should be further explored in future studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5966\/sctm.2015-0023","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T01:40:39Z","timestamp":1437529239000},"page":"1073-1085","source":"Crossref","is-referenced-by-count":69,"title":["Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects"],"prefix":"10.1093","volume":"4","author":[{"given":"Silvia","family":"Cerri","sequence":"first","affiliation":[{"name":"Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Greco","sequence":"additional","affiliation":[{"name":"Laboratory of Neurophysiology of Integrative Autonomic Systems, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Levandis","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ghezzi","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina Stefania","family":"Mangione","sequence":"additional","affiliation":[{"name":"Laboratory of Neurophysiology of Integrative Autonomic Systems, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Fuzzati-Armentero","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bonizzi","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Avanzini","sequence":"additional","affiliation":[{"name":"Immunology and Transplantation Laboratory\/Cell Factory\/Pediatric Hematology\/Oncology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Maccario","sequence":"additional","affiliation":[{"name":"Immunology and Transplantation Laboratory\/Cell Factory\/Pediatric Hematology\/Oncology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Blandini","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Neurochemistry, Center for Research in Neurodegenerative Diseases, \u201cC. Mondino\u201d National Neurological Institute, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"2021122704421248900_R1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/brain\/119.1.41","article-title":"Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach","volume":"119","author":"Defer","year":"1996","journal-title":"Brain"},{"key":"2021122704421248900_R2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease","volume":"327","author":"Freed","year":"1992","journal-title":"N Engl J Med"},{"key":"2021122704421248900_R3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"2021122704421248900_R4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJM198801073180115","article-title":"Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease","volume":"318","author":"Madrazo","year":"1988","journal-title":"N Engl J Med"},{"key":"2021122704421248900_R5","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model","volume":"99","author":"Bj\u00f6rklund","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704421248900_R6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2005.12.140","article-title":"Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model","volume":"341","author":"Cho","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2021122704421248900_R7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI21137","article-title":"Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model","volume":"115","author":"Takagi","year":"2005","journal-title":"J Clin Invest"},{"key":"2021122704421248900_R8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.wco.0000174298.27765.91","article-title":"Stem cell treatment for Parkinson's disease: An update for 2005","volume":"18","author":"Snyder","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"2021122704421248900_R9","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1073\/pnas.1010209107","article-title":"Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats","volume":"107","author":"Hargus","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704421248900_R10","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI45794","article-title":"Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease","volume":"121","author":"Rhee","year":"2011","journal-title":"J Clin Invest"},{"key":"2021122704421248900_R11","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704421248900_R12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0960327114524238","article-title":"Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model?","volume":"33","author":"Ahmed","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"2021122704421248900_R13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12015-014-9551-y","article-title":"Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids","volume":"11","author":"Berg","year":"2015","journal-title":"Stem Cell Rev"},{"key":"2021122704421248900_R14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3727\/096368909X479839","article-title":"Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat","volume":"19","author":"Blandini","year":"2010","journal-title":"Cell Transplant"},{"key":"2021122704421248900_R15","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuint.2008.02.003","article-title":"Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease","volume":"52","author":"Bouchez","year":"2008","journal-title":"Neurochem Int"},{"key":"2021122704421248900_R16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7150\/ijms.8182","article-title":"Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: A comparison study of mononuclear and mesenchymal stem cells","volume":"11","author":"Capitelli","year":"2014","journal-title":"Int J Med Sci"},{"key":"2021122704421248900_R17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","article-title":"Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease","volume":"216","author":"Chao","year":"2009","journal-title":"J Neuroimmunol"},{"key":"2021122704421248900_R18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/glia.20731","article-title":"Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action","volume":"57","author":"Kim","year":"2009","journal-title":"Glia"},{"key":"2021122704421248900_R19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","article-title":"Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease","volume":"107","author":"Park","year":"2008","journal-title":"J Neurochem"},{"key":"2021122704421248900_R20","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.neurobiolaging.2014.01.028","article-title":"Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model","volume":"35","author":"Park","year":"2014","journal-title":"Neurobiol Aging"},{"key":"2021122704421248900_R21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/scd.2008.0411","article-title":"Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease","volume":"18","author":"Sadan","year":"2009","journal-title":"Stem Cells Dev"},{"key":"2021122704421248900_R22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2014.10.039","article-title":"Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats","volume":"584","author":"Suzuki","year":"2015","journal-title":"Neurosci Lett"},{"key":"2021122704421248900_R23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.coph.2006.02.008","article-title":"Regenerative and immunomodulatory potential of mesenchymal stem cells","volume":"6","author":"Krampera","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"2021122704421248900_R24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","article-title":"Risk of tumorigenicity in mesenchymal stromal cell-based therapies\u2014bridging scientific observations and regulatory viewpoints","volume":"15","author":"Barkholt","year":"2013","journal-title":"Cytotherapy"},{"key":"2021122704421248900_R25","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","article-title":"Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms","volume":"67","author":"Bernardo","year":"2007","journal-title":"Cancer Res"},{"key":"2021122704421248900_R26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1365-2184.2008.00559.x","article-title":"Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow","volume":"41","author":"Choumerianou","year":"2008","journal-title":"Cell Prolif"},{"key":"2021122704421248900_R27","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2174\/1381612811319130015","article-title":"Mesenchymal stem\/stromal cells: A new \u201ccells as drugs\u201d paradigm. Efficacy and critical aspects in cell therapy","volume":"19","author":"de Girolamo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2021122704421248900_R28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/stem.1118","article-title":"Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation","volume":"30","author":"von Bahr","year":"2012","journal-title":"Stem Cells"},{"key":"2021122704421248900_R29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2009.11.041","article-title":"Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease","volume":"1311","author":"Cova","year":"2010","journal-title":"Brain Res"},{"key":"2021122704421248900_R30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis","volume":"198","author":"Crigler","year":"2006","journal-title":"Exp Neurol"},{"key":"2021122704421248900_R31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12015-010-9190-x","article-title":"Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice","volume":"7","author":"Kan","year":"2011","journal-title":"Stem Cell Rev"},{"key":"2021122704421248900_R32","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.biochi.2013.07.013","article-title":"The secretome of mesenchymal stem cells: potential implications for neuroregeneration","volume":"95","author":"Paul","year":"2013","journal-title":"Biochimie"},{"key":"2021122704421248900_R33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol"},{"key":"2021122704421248900_R34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/mp.2009.110","article-title":"Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior","volume":"15","author":"Tfilin","year":"2010","journal-title":"Mol Psychiatry"},{"key":"2021122704421248900_R35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl Res"},{"key":"2021122704421248900_R36","doi-asserted-by":"crossref","first-page":"931902","DOI":"10.1155\/2012\/931902","article-title":"Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: A pilot clinical study","volume":"2012","author":"Venkataramana","year":"2012","journal-title":"Stem Cells Int"},{"key":"2021122704421248900_R37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"Lee","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"2021122704421248900_R38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"key":"2021122704421248900_R39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jvir.2010.01.008","article-title":"Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease","volume":"21","author":"Brazzini","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"2021122704421248900_R40","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","article-title":"6-Hydroxydopamine-induced alterations in blood-brain barrier permeability","volume":"22","author":"Carvey","year":"2005","journal-title":"Eur J Neurosci"},{"key":"2021122704421248900_R41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann Neurol"},{"key":"2021122704421248900_R42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1742-2094-9-188","article-title":"Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease","volume":"9","author":"Pisani","year":"2012","journal-title":"J Neuroinflammation"},{"key":"2021122704421248900_R43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12248-008-9018-7","article-title":"Recent advances in blood-brain barrier disruption as a CNS delivery strategy","volume":"10","author":"Bellavance","year":"2008","journal-title":"AAPS J"},{"key":"2021122704421248900_R44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2008.05.080","article-title":"Mannitol enhances delivery of marrow stromal cells to the brain after experimental intracerebral hemorrhage","volume":"1224","author":"Seyfried","year":"2008","journal-title":"Brain Res"},{"key":"2021122704421248900_R45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2013.08.058","article-title":"Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after traumatic brain injury","volume":"554","author":"Okuma","year":"2013","journal-title":"Neurosci Lett"},{"key":"2021122704421248900_R46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","article-title":"Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model","volume":"25","author":"Blandini","year":"2007","journal-title":"Eur J Neurosci"},{"key":"2021122704421248900_R47","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998","edition":"7th ed."},{"key":"2021122704421248900_R48","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble beta amyloid(1-42): A critical player in producing behavioural and biochemical changes evoking depressive-related state?","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2021122704421248900_R49","first-page":"R421","article-title":"Quantitative aspects of reversible osmotic opening of the blood-brain barrier","volume":"238","author":"Rapoport","year":"1980","journal-title":"Am J Physiol"},{"key":"2021122704421248900_R50","first-page":"R443","article-title":"Blood-brain barrier disruption using mannitol: time course and electron microscopy studies","volume":"256","author":"Cosolo","year":"1989","journal-title":"Am J Physiol"},{"key":"2021122704421248900_R51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-60761-938-3_23","article-title":"Blood-brain barrier disruption in the treatment of brain tumors","volume":"686","author":"Blanchette","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2021122704421248900_R52","doi-asserted-by":"crossref","first-page":"37470","DOI":"10.1155\/IJBI\/2006\/37470","article-title":"Increased depth of cellular imaging in the intact lung using far red and near infrared fluorescent probes","volume":"2006","author":"Al-Mehdi","year":"2006","journal-title":"Int J Biomed Imag"},{"key":"2021122704421248900_R53","first-page":"435","article-title":"Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease","volume":"7","author":"Bossolasco","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"2021122704421248900_R54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.STR.0000157661.69482.76","article-title":"Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats","volume":"36","author":"Hanabusa","year":"2005","journal-title":"Stroke"},{"key":"2021122704421248900_R55","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/1521-4141(2000)30:8<2245::AID-IMMU2245>3.0.CO;2-7","article-title":"The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection","volume":"30","author":"Lehner","year":"2000","journal-title":"Eur J Immunol"},{"key":"2021122704421248900_R56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/stem.293","article-title":"Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury","volume":"28","author":"Morigi","year":"2010","journal-title":"Stem Cells"},{"key":"2021122704421248900_R57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/08820130701812584","article-title":"Cell tracking 2007: A proliferation of probes and applications","volume":"36","author":"Wallace","year":"2007","journal-title":"Immunol Invest"},{"key":"2021122704421248900_R58","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J Neurosci"},{"key":"2021122704421248900_R59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2007.08.012","article-title":"Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease","volume":"1176","author":"Tassorelli","year":"2007","journal-title":"Brain Res"},{"key":"2021122704421248900_R60","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"West","year":"1991","journal-title":"Anat Rec"},{"key":"2021122704421248900_R61","doi-asserted-by":"crossref","DOI":"10.7243\/2050-1218-2-4","article-title":"Molecular mechanisms of migration and homing of intravenously transplanted mesenchymal stem cells","author":"Kholodenko","year":"2013","journal-title":"J Regen Med Tissue Eng"},{"key":"2021122704421248900_R62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/bjaceaccp\/mkr063","article-title":"Mannitol: a review of its clinical uses","volume":"2","author":"Shawkat","year":"2012","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"2021122704421248900_R63","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jgm.452","article-title":"Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome","volume":"5","author":"Chapel","year":"2003","journal-title":"J Gene Med"},{"key":"2021122704421248900_R64","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yjmcc.2008.01.004","article-title":"Homing and engraftment of progenitor cells: a prerequisite for cell therapy","volume":"45","author":"Chavakis","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"2021122704421248900_R65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","article-title":"Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke","volume":"27","author":"Shen","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"2021122704421248900_R66","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuroscience.2010.11.054","article-title":"Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats","volume":"175","author":"Guti\u00e9rrez-Fern\u00e1ndez","year":"2011","journal-title":"Neuroscience"},{"key":"2021122704421248900_R67","doi-asserted-by":"crossref","first-page":"e54963","DOI":"10.1371\/journal.pone.0054963","article-title":"In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"2021122704421248900_R68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1179\/1743132812Y.0000000152","article-title":"Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats","volume":"35","author":"Ruan","year":"2013","journal-title":"Neurol Res"},{"key":"2021122704421248900_R69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainres.2008.06.123","article-title":"Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats","volume":"1233","author":"Pavlichenko","year":"2008","journal-title":"Brain Res"},{"key":"2021122704421248900_R70","doi-asserted-by":"crossref","first-page":"16267","DOI":"10.1073\/pnas.242435499","article-title":"Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat","volume":"99","author":"Hoehn","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704421248900_R71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/scrt17","article-title":"Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: A longitudinal imaging study","volume":"1","author":"Jackson","year":"2010","journal-title":"Stem Cell Res Ther"},{"key":"2021122704421248900_R72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuroimage.2003.08.030","article-title":"Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study","volume":"21","author":"Modo","year":"2004","journal-title":"Neuroimage"},{"key":"2021122704421248900_R73","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/STROKEAHA.107.502047","article-title":"Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia","volume":"39","author":"Walczak","year":"2008","journal-title":"Stroke"},{"key":"2021122704421248900_R74","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"2021122704421248900_R75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","article-title":"Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution","volume":"108","author":"Barbash","year":"2003","journal-title":"Circulation"},{"key":"2021122704421248900_R76","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","article-title":"Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction","volume":"112","author":"Kraitchman","year":"2005","journal-title":"Circulation"},{"key":"2021122704421248900_R77","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/08830185.2010.498931","article-title":"Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications","volume":"29","author":"Deak","year":"2010","journal-title":"Int Rev Immunol"},{"key":"2021122704421248900_R78","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021122704421248900_R79","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/14653240802021330","article-title":"Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease","volume":"10","author":"Levy","year":"2008","journal-title":"Cytotherapy"},{"key":"2021122704421248900_R80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresprot.2005.03.002","article-title":"Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease","volume":"15","author":"Lu","year":"2005","journal-title":"Brain Res Brain Res Protoc"},{"key":"2021122704421248900_R81","doi-asserted-by":"crossref","first-page":"e64000","DOI":"10.1371\/journal.pone.0064000","article-title":"Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model","volume":"8","author":"Yan","year":"2013","journal-title":"PLoS One"},{"key":"2021122704421248900_R82","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2012.05.032","article-title":"Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior","volume":"1466","author":"Park","year":"2012","journal-title":"Brain Res"},{"key":"2021122704421248900_R83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"2021122704421248900_R84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00242905","article-title":"Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression","volume":"108","author":"Labandeira-Garcia","year":"1996","journal-title":"Exp Brain Res"},{"key":"2021122704421248900_R85","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1167\/iovs.11-7346","article-title":"Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes","volume":"52","author":"Harper","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122704421248900_R86","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cbin.10217","article-title":"Salidroside induces rat mesenchymal stem cells to differentiate into dopaminergic neurons","volume":"38","author":"Zhao","year":"2014","journal-title":"Cell Biol Int"},{"key":"2021122704421248900_R87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"2021122704421248900_R88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnsys.2011.00060","article-title":"The role of BDNF\/TrkB signaling in acute amphetamine-induced locomotor activity and opioid peptide gene expression in the rat dorsal striatum","volume":"5","author":"McGinty","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"2021122704421248900_R89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0006-8993(99)02116-2","article-title":"Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer","volume":"847","author":"Klein","year":"1999","journal-title":"Brain Res"},{"key":"2021122704421248900_R90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2005.05.072","article-title":"Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease","volume":"1052","author":"Sun","year":"2005","journal-title":"Brain Res"},{"key":"2021122704421248900_R91","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"2021122704421248900_R92","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0306-4522(96)00248-5","article-title":"Behavioral and neurochemical dysfunction in the circling (ci) rat: a novel genetic animal model of a movement disorder","volume":"74","author":"L\u00f6scher","year":"1996","journal-title":"Neuroscience"},{"key":"2021122704421248900_R93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0306-4522(02)00013-1","article-title":"Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance","volume":"111","author":"Metz","year":"2002","journal-title":"Neuroscience"},{"key":"2021122704421248900_R94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/brain\/109.5.805","article-title":"The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat","volume":"109","author":"Whishaw","year":"1986","journal-title":"Brain"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0023","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0023","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/4\/9\/1073\/41864770\/stcltm_4_9_1073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/4\/9\/1073\/41864770\/stcltm_4_9_1073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:49:30Z","timestamp":1642560570000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/4\/9\/1073-1085\/6397324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":94,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,7,21]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0023","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9,1]]},"published":{"date-parts":[[2015,7,21]]}}}